Forerunner Closes $28 Million Funding For Medical Devices
publication date: Sep 14, 2020
Forerunner Medical (Shanghai) closed a Series B funding that raised at least $28 million, though the exact amount was not disclosed. Forerunner makes minimally invasive ablation/coagulation medical devices, especially low-temperature plasma radio-frequency devices and electrodes for sport medicine, spinal disk repair and ENT treatment. In cancer, its products are approved in China to treat liver, lung, thyroid, breast and other cancers. The funding was led by CICC Capital, with participation from Cenova Capital, Apricot Capital, Dalton Venture and Huaxing Capital. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.